Law Firm | Canadian Lawyer

LAW FIRMS
- Cases
- Fogler, Rubinoff LLP
- Deals
CASES
DEALS

Fogler, Rubinoff LLP

Hearing Date: 19 May 2023

HENVEY INLET FIRST NATION v. JOSEPH HERBERT, SR.

CourtFederal Court

Case NumberT-1975-21

Practice AreaReal estate

ClientsHENVEY INLET FIRST NATION, JOSEPH HERBERT, SR., AGC, Ontario
Hearing Date: 25 Apr 2023

RIVERSIDE HUMBER CORP. ET AL v 1000118885 ONTARIO INC.

CourtCommercial List

Case NumberCV-23-00693333-00CL

Practice AreaCorporate & commercial law

ClientsRIVERSIDE HUMBER CORP., 2205633 ONTARIO LIMITED, 16220375 ONTARIO INC., 1000118885 ONTARIO INC.
Hearing Date: 23 Mar 2023

PAYCORE MINERALS INC. v PAYCORE MINERALS INC. (SHAREHOLDERS,OPTION HOLDERS,WARRANT HOLDERS,DIRECTORS,AUDITOR) ET AL

CourtCommercial List

Case NumberCV-23-00696354-00CL

Practice AreaCorporate & commercial law

ClientsPAYCORE MINERALS INC., PAYCORE MINERALS INC. (SHAREHOLDERS,OPTION HOLDERS,WARRANT HOLDERS,DIRECTORS,AUDITOR), WATERTON NEVADA SPLITTER, LLC, WATERTON NEVADA SPLITTER II, LLC, I-80 GOLD CORP.
Hearing Date: 7 Nov 2022

12823543 Canada Ltd. v. Mizrahi Commercial (The One) GP Inc.

CourtSuperior Court of Justice - Ontario

Case NumberCV-22-00685567-00CL

Practice AreaCorporate & commercial law

Clients12823543 CANADA LTD, MIZRAHI COMMERCIAL (THE ONE) GP INC., MIZRAHI COMMERCIAL (THE ONE) LP, SAM M INC., SAM MIZRAHI

Showing 61 to 64 of 64 entries

1 2 3 4 5 6 7

MOST ACTIVE FIRMS

01

Gowling WLG (Canada) LLP

Case 299 | Deals 91

02

McCarthy Tétrault LLP

Case 260 | Deals 348

03

Borden Ladner Gervais LLP (BLG)

Case 237 | Deals 155

04

Miller Thomson LLP

Case 207 | Deals 64

05

Fasken Martineau DuMoulin LLP

Case 204 | Deals 226

RECENTLY ADDED DEALS

13 Mar 2025

ECN Capital Corp. announces $75 million convertible debenture offering

12 Mar 2025

AtkinsRéalis sells remaining stake in Highway 407 ETR for $2.79 billion

11 Mar 2025

Canadian Pacific Railway prices US$1.2 billion notes offering

10 Mar 2025

Nutrien Ltd. prices US$1 billion senior notes offering

10 Mar 2025

Knight Therapeutics to acquire Paladin